Cell membrane anionic components

Cell membrane anionic components refer to a diverse group of negatively charged molecules located on the outer leaflet of cellular membranes, including anionic phospholipids like phosphatidylserine, as well as glycosaminoglycans and sialic acid-containing glycoproteins. In healthy mammalian cells, these components are often sequestered or balanced to maintain a neutral or zwitterionic outer surface; however, in pathological states such as cancer or bacterial infection, the density of these anionic molecules increases significantly on the exterior surface. This shift creates a selective therapeutic window, allowing cationic antimicrobial peptides and certain monoclonal antibodies to preferentially bind to diseased cells over healthy ones. In oncology, the exposure of phosphatidylserine is a key marker of the tumor microenvironment and immunosuppression, making it a target for immune-modulating therapies. In infectious diseases, the anionic nature of bacterial membranes (due to lipopolysaccharides or lipoteichoic acids) is the primary target for polymyxins and other membrane-disrupting antibiotics.

Other names

Anionic membrane lipidsNegatively charged membrane componentsAnionic phospholipidsSurface polyanions

Drugs targeting these components typically utilize electrostatic attraction to bind to the negatively charged cell surface, leading to membrane disruption, pore formation, or the induction of antibody-dependent cellular cytotoxicity (ADCC).